Phylloseptine-PBa1, -PBa2, -PBa3: Three novel antimicrobial peptides from the skin secretion of Burmeister's leaf frog (Phyllomedusa burmeisteri)
Introduction
Antimicrobial peptides (AMPs) are an important participant of the host defence system and play an important role in the innate immunity and the acquired immunity, thus, they also are hailed as the first line of self-defence [1] [2] [3] . In the past few decades, through the studies on the self-defense systems ranging from plants to animals, as well as microorganisms, researchers have found that AMPs can be obtained from many organisms [4] [5] [6] [7] [8] [9] [10] . Furthermore, because the amphibians are lacking in robust cellular immunity, antimicrobial peptides have become even more important in their host defence system. In the 1960s, investigations on the yellow-bellied toad (Bombina variegata), discovered a new family of antimicrobial peptides named "bombinins", which was the first discovery of antimicrobial peptides from frogs with associated haemolytic activity [11] . Hereafter, AMPs from amphibian skin secretion caught increasing attention as a high potential future antibiotic candidate, for their abilities against resistant microorganisms [12] .
In the past few years, a series of investigations have been performed on the leaf frogs of the Phyllomedusinae subfamily. These tree frogs inhabit the vast rainforests of Central and South America and have diversified into seven genera and almost sixty species [13] . So far, abundant peptides with antimicrobial activities have been isolated from their skin secretions. Phylloseptins were first isolated from two species of the Phyllomedusa genus (Phyllomedusa oreades and Phyllomedusa hypochondrialis) and characterised according to their observed antimicrobial activities in 2005 [14] .
Subsequent to the initial discovery, phylloseptins were isolated from the skin secretions of many more species from the Phyllomedusinae subfamily [15] [16] [17] [18] [19] [20] . There are highlyconserved domains in the signal peptide and acidic spacer peptide domains that are located in the N-terminal regions of all the reported phylloseptins biosynthetic precursors cloned from different species and they generally consist of 15-21 amino acids with similar primary structures. Phylloseptins were reported to have a significant activity against Gram-positive and Gram-negative bacteria and also yeast with an insignificant haemolysis activity at determined MIC concentrations [16.17] . In a hydrophobic environment or in the membrane, phylloseptins will form into amphiphilic α-helical structures (the polar amino acids, especially the positively-charged lysines and arginines form into the hydrophilic surface, while the non-polar amino acids form into the hydrophobic surface), that might explain their specific recognition of eukaryotic and prokaryotic cell membranes [14.16.19 ]. In the most recent research, there even reported one phylloseptin peptide was found to have the ability to promote insulin secretion [21] .
In this study, "shotgun" cloning procedures were performed and achieved three novel phylloseptin precursor encoding peptides, which were classified as Phylloseptine-PBa1, -PBa2 and -PBa3, from the defensive skin secretion-derived cDNA library of Burmeister's leaf frog (Phyllomedusa burmeisteri). The chemically-synthesised peptides were then subjected to antimicrobial, anticancer and haemolysis assays.
Material and method

Specimen biodata and harvest of skin secretion
Adult Burmeister's leaf frog (phyllomedusa burmeisteri) (n=4, both sexes, 5-7 cm snout-to-vent length) was obtained from a commercial source and had been captivebred in the United States. For secretion harvesting, the frogs were bred with multivitamin-loaded cricket feeding three times a week, under artificial controlling conditions with a daily 12 h light exposure at 20-25 ºC for 100 days. Defensive skin secretion was obtained with mild transdermal electrical stimulation (5V, 100Hz, 140ms pulse width) (C.F. Palmer, UK) applied on the dorsal skin surface and flushed with deionised water, then lyophilized and stored at -20 ºC for use. All procedures on living animals were vetted by the IACUC of Queen's University Belfast to approved through the animal experimentation ethics and performed under the guidelines issued by the Department of Health, Social Services and Public Safety, Northern Ireland.
"Shotgun" Cloning of phylloseptin precursor-encoding cDNA
Polyadenylated mRNA was isolated from the redissolved P. burmeisteri skin secretion with Dynabeads mRNA Direct Kits (Thermo Fisher, USA), then subjected to the rapid amplification of cDNA 3'-ends (3'-RACE) procedures, which a nested universal (NUP) primer and a sense primer (5'-ACTTTCYGAWTTRYAAGMCCAAABATG-3') that was designed to a segment of the 5'-untranslated region of phylloxin cDNA from Phyllomedusa bicolor (EMBL Accession no. AJ251876) and the opioid peptide cDNA from Pachymedusa dacnicolor (EMBL Accession no. AJ005443) were employed to obtain full-length preprophylloseptin nucleic acid sequence data using a SMART-RACE kit (Clontech, UK) essentially as described by the manufacturer. The polymerase chain reaction (PCR)
cycling procedure was carried out as follows: Initial denaturation step for 90 s at 94 ºC, for 180 s at 72 ºC. PCR products were subjected to gel-purification and cloning by using a pGEM-T vector system (Promega, USA), then sequenced by using an ABI 3100
Automated Capillary Sequencer (Biosystems, USA).
Identification and structural analyses of novel phylloseptins in skin secretion
Lyophilised P. burmeisteri skin secretion was dissolved in of trifluoroacetic acid 
Solid-phase peptide synthesis of novel phylloseptins and secondary structure prediction
The novel cloned phylloseptins were chemically-synthesised by solid-phase Fmoc chemistry by using a PS3 automated solid-phase synthesiser (Protein Technologies Inc., USA), followed by resin cleavage and side-chain deprotection. As reverse phase HPLC was employed for purification of synthetic peptide purification, the mass spectrometer was applied for structure authentication. The helical wheel projections and relevant physiochemical parameters of peptides, such as the proportion of nonpolar residues, hydrophobicity, hydrophobic moment, and net charge, were achieved by use of Heliquest (http://heliquest.ipmc.cnrs.fr/) [22] , while PredictProtein (https://www.predictprotein.org/) [23] was performed for the prediction of the α-helical proportion and transmembrane domain.
Antimicrobial assay
The antimicrobial activity of three synthetic novel phylloseptins was evaluated via 
Cell Viability of human cancer cells
The synthesized phylloseptins were prepared in concentration of 10 - cells were added to wells of the 96-well plates and incubated for 24 h at 37 °C under 5% CO2, followed by 12 h incubation with serum-free medium for cell starving. The prepared peptide solutions (in serum-free medium) were added to the wells and incubated for 72 h. A certain amount of MTT solution (5 mg/mL) was added to each well for 6 h of incubation, then the solutions (both MTT and medium) in each well were removed and the precipitated formazan crystals were redissolved in DMSO. The Synergy HT reader (Biotek, USA) was employed to measure the OD value at 550nm.
Hemolysis assay
The hemolytic activity of each synthetic phylloseptins was determined against 2% 
Isolation and structural characterisation of Phylloseptin-PBa1, -PBa2, -PBa3
In order to confirm the existence of predicted phylloseptins, which were encoded from the skin secretion-derived cDNA library, RP-HPLC and MS/MS fragmentation sequencing were employed to analyze the Phyllomedusa burmeisteri skin secretion.
The retention times of these novel phylloseptins were approximately around 120min, and the identities of amino acid sequences have also been verified ( Figure 2 and Table   1 , respectively).
Physicochemical properties and secondary structures prediction of
Phylloseptin-PBa1, -PBa2, -PBa3
As shown in the wheel projects, K 17 -Phylloseptin-PBa1 and K 18 -Phylloseptin-PBa2 were both located in-between hydrophilic and hydrophobic face, as the positively charged C'-terminal of all three phylloseptins were located in the middle of the hydrophobic face ( Figure 3 . A-C). The predicted secondary structure showed that these phylloseptins exhibited a coil-helix-coil construction (Figure 3 proportion of α-helical domain, which had been deemed to play an important role of antimicrobial mechanism of AMPs, and a similar degree of hydrophobicity and hydrophobic moment while Phylloseptin-PBa3 has one more nonpolar residue than
Phylloseptin-PBa1 and -PBa2 ( Table 2 ).
Antimicrobial activities
Both of Phylloseptin-PBa1 and -PBa2 possessed relatively strong growth inhibitory effects against S.aureus and C.albicans but exhibited weak activities against E.coli ( Table 3) 
Hemolysis activity
These three phylloseptins exhibited different degrees of hemolytic activities against red blood cells. Nevertheless, Phylloseptin-PBa3 showed a much weaker effect than Phylloseptin-PBa1 and -PBa2, the HC50 of Phylloseptin-PBa1, -PBa2 and -PBa3 were 18.60μM, 15.82μM and 53.98μM, respectively (Figure 4 . C).
Discussions
In recent years, the mode of action of antimicrobial peptides has been studied extensively. Even though the exact mechanism of how such peptides kill microorganisms still needs to be clarified, there is no doubt that peptide-lipid interactions rather than receptor-mediated recognition processes play a key role in the function of most membrane-lytic peptides [24] . AMPs employ some specific stepsattraction, attachment, insertion and membrane permeability to induce killing of bacteria. Though varying greatly in sequences, AMPs generally consist of 12 to 50 amino acids and tend to contain two or more positively-charged amino acids so that they can partition into the bacteria membrane lipid bilayer, which is negatively-charged for their richness of anionic teichoic acids (Gram-positive bacteria) or phospholipids and phosphate groups and teichoic acids (Gram-negative bacteria). [25] Similarly, it goes without saying that the electrostatic attraction between the negatively-charged membranes of cancer cells and AMPs is believed to play an important role in the disruption of cancer cell membranes [26] . Interestingly, many natural AMPs are found to have an amidated C'-terminal that would neutralize the typical C-terminal carboxyl group. There are two possible reasons for this: firstly, peptides will be able to reduce their negative charge that might cause a decrease in their α-helicity; secondly, the increasing of the hydrophobic nature of this region may improve membrane interaction and hence antimicrobial activity [16] .
By studying comparatively (Table 4) , the antimicrobial activities of reported phylloseptins demonstrated broad-spectrum activities, but the specific antibacterial spectrum of each peptide was different for their unique primary structure. Based on statistics and analysis, it is easy to find out phylloseptins were linear cationic α-helical peptides with a relatively conservative N-terminal domain and a highly variable amidated C-terminal (Table 4 ). Different from other AMPs, such as brevinins and magainins which contained numerous positively charged amino acids, naturally produced phylloseptins were normally possessed positive net charge less than three with an amidated C-terminal. By comparison, antimicrobial activities of the single charged phylloseptins were obviously weaker than the double charged phylloseptins while triple charged phylloseptins didn't present significant stronger activities.
Recently, a study on the designed cationicity-enhanced phylloseptin analogs showed importation of voluminous lysine (net charge of +6) do not lead to prominent improvement of antimicrobial activities but possible increasing of hemolysis activities [27] . Therefore, lysine located in last three residues of the C-terminal must be playing an important role in phylloseptin's feature. Resende J. M. suggested that the specific lysine was able to create a tilt angle to lifted and moved the C-terminal away from the membrane barrier and dived the N-terminal and α-helical domain into the membrane interior, that developed the function of membrane interface partition and disorder [19] .
In addition, some specific amino acid position [20] were also considered to be highly relevant to antimicrobial activities, that might explain the significant activity differences between highly similar Phylloseptin-L1 and Phylloseptin-PLS-S5,
Phylloseptin-PTa and Phylloseptin-PC.
This study reports the discovery of three novel phylloseptins from skin secretion of Phyllomedusa burmeisteri. As pair of primers (one NUP and a designed degenerate sense primer) were employed for "shotgun" cloning, three preprophylloseptin fulllength cDNAs were consistently cloned from the skin secretion-derived cDNA library and each encoded a single copy of a novel mature peptide. The alignment of the three translated open-reading frame amino acid sequences showed highly-conserved signal peptide domains of 22 amino acid residues. The signal peptides of Phylloseptin-PBa2 and -PBa3 were followed by a highly-conserved acidic spacer domain that terminates in a typical -Lys-Arg-(-KR) propeptide convertase processing motif, while the propeptide convertase processing motif of Phylloseptin-PBa1 was -Glu-Arg-(-ER-).
All three encoded mature peptides were 19 amino acid residues in length with a C'terminal amidation. Moreover, the positively charged K 17 -Phylloseptin-PBa1 and K 18 -Phylloseptin-PBa2 were both located in between the α-helical domain and random coil domain of C-terminal, which speculated to enhance the activities by creating an insert alignment angle and improving membrane interaction [19] . Therefore, chemosynthetic In conclusion, these studies clarified a method to identify novel naturally produced bioactive peptides from amphibian skin secretion, and also provide valuable clues for the design of analogs with higher activities and lower biological hazard, which might lead to an evolution of anti-infective and anti-tumor drug. ND: not detected. Physicochemical parameters were predicted by online analysis tool HeliQuest and PredictProtein.
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